Balance Sheet

Accounts Payables Accumulated Expenses Assets Capital Leases Cash & Current Investments Cash & Equivalents Common Equity Convertible Debt Current Assets Current Deferred Revenue Current Deferred Tax Assets Current Deferred Tax Assets Current Leases Finished Goods Goodwill Goodwill & Intangibles Intangibles Inventory Liabilities and Shareholders Equity Minority Interest Non-Current Assets Non-Current Debt Non-Current Deffered Revenue Notes Payables Operating Leases Other Accumulated Expenses Other Non-Current Assets Other Non-Current Liabilities Payables Preferred Stock Liabilities Prepaid Assets Property, Plant & Equipment (Net)Property, Plant & Equipment (Net)Raw Materials Receivables Receivables - Net Receivables - Other Retained Earnings Shareholder's Equity Shares Outstanding Short term Debt Total Current Liabilities Total Debt Total Liabilities Total Non-Current Liabilities Treasury Shares Work In Process

Cash Flow Statement

Daily Values

Growth Metrics

Ekso Bionics Holdings (EKSO) Short term Debt (2025 - 2026)

Ekso Bionics Holdings has reported Short term Debt over the past 2 years, most recently at $2.0 million for Q4 2025.

On a quarterly basis, Short term Debt changed N/A to $2.0 million in Q4 2025 year-over-year; TTM through Dec 2025 was $2.0 million, a N/A change, with the full-year FY2025 number at $2.0 million, changed N/A from a year prior.
Short term Debt reached $2.0 million in Q4 2025 per EKSO's latest filing, up from $1.9 million in the prior quarter.
The five-year high for Short term Debt was $2.0 million in Q4 2025, with the low at $1.9 million in Q3 2025.